加速度计测量的体力活动与肥厚型心肌病患者生活质量的关系
本研究用7天加速度计评估203例肥厚型心肌病(HCM)患者和37例基因阳性表型阴性(G+/P-)个体的体力活动,发现HCM患者步数更少、中高强度活动更少、久坐更常见,症状性、梗阻性或肥胖者活动最低;每日步数轻度增加与更好生活质量相关。
要点
- HCM患者客观体力活动显著低于G+/P-个体,症状性、梗阻性或肥胖者最低。
- 每日步数增加250步对应KCCQ评分高2.15分,增加1000步对应EQ-5D-5L高0.05分。
- 多数HCM患者曾获运动指导并因此减少活动,提示需个体化运动咨询。
核心结论
- HCM患者客观测量的体力活动显著低于G+/P-个体,症状性、梗阻性或肥胖者活动水平最低。
- 每日步数轻度增加与更好的生活质量评分独立相关。
研究设计与样本
- 单中心观察性研究,纳入203例HCM患者和37例基因阳性表型阴性(G+/P-)个体,使用7天加速度计评估体力活动。
- 生活质量采用堪萨斯城心肌病问卷(KCCQ)和EuroQoL五维五水平量表(EQ-5D-5L)测量。
主要发现
- HCM患者每日步数5254步,低于G+/P-个体的6573步(p<0.01)。
- HCM患者中高强度体力活动(MVPA)占每日3.4%,低于G+/P-个体的4.5%(p<0.01)。
- HCM患者中61%每日久坐时间超过80%,高于G+/P-个体的35%(p<0.01)。
- 无症状梗阻性HCM患者的活动水平与症状性患者相当。
- 每日步数增加250步对应KCCQ评分高2.15分,增加1000步对应EQ-5D-5L评分高0.05分(均p<0.001),校正年龄和性别后仍显著。
临床怎么用
- 对HCM患者应基于临床表型(症状、梗阻、肥胖)进行个体化运动咨询,而非普遍建议减少活动。
- 每日步数可作为评估HCM患者活动水平与生活质量的简易指标。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with hypertrophic cardiomyopathy (HCM) often reduce their physical activity due to concerns about sudden cardiac death. However, objective data on activity patterns in HCM, particularly in relation to clinical phenotype and quality of life (QoL), remain limited. METHODS: We assessed physical activity using 7-day accelerometry in 203 patients with HCM and 37 genotype-positive, phenotype-negative (G+/P-) individuals. Outcomes included daily step counts, time spent in moderate-to-vigorous physical activity (MVPA) and sedentariness. QoL was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the EuroQoL 5-domain 5-level (EQ-5D-5L). RESULTS: HCM patients took fewer steps/day (5254 vs 6573), engaged in less MVPA (3.4% vs 4.5% of the day) and were more often sedentary (61% vs 35% spending >80% of the day sedentary) compared with G+/P- controls (all p<0.01). Symptomatic and obstructive HCM patients showed the lowest activity levels. Notably, asymptomatic obstructive HCM patients demonstrated reduced activity comparable to symptomatic individuals. Obesity and use of cardiac medications were also associated with lower activity. Step counts were positively associated with QoL scores: a 250 steps/day increment corresponded to a 2.15-point higher KCCQ score and a 1000 steps/day increment to a 0.05-point higher EQ-5D-5L score (both p<0.001), remaining significant after adjustment for age and sex. Most HCM patients (62%) recalled receiving exercise guidance, and many (59%) reported reducing their activity as a result. CONCLUSIONS: Objectively measured physical activity was significantly lower in HCM patients compared with G+/P- individuals, particularly among those with symptoms, obstruction or obesity. Even modestly higher daily step counts were associated with better QoL, highlighting the relevance of individualised, phenotype-informed exercise counselling in HCM.
引用
- Schoonvelde SAC, Zwetsloot PP, Hirsch A, et al. Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy. Heart. 2026. PMID: 40887133. doi:10.1136/heartjnl-2025-326217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。